Oral Glucose-Lowering Agents for the Treatment of Type 2 Diabetes Mellitus
The Singapore Family Physician
;
: 6-11, 2019.
Article
in English
| WPRIM
| ID: wpr-731902
ABSTRACT
@#Family physicians manage the majority of patients with type 2 diabetes mellitus (T2DM) in Singapore. Hence, they should be familiar with the profile of the many available oral glucose-lowering agents. These drugs vary in their mechanisms of action, glucose-lowering efficacy, safety profiles and treatment costs between classes – even within classes in some cases. These factors should be carefully considered for a patient-centred approach to selecting oral glucose-lowering therapy. This review aims to describe the characteristics of various oral glucose-lowering agents available to family physicians in the management of T2DM and the impact of these characteristics on the patient-centric approach to treatment decision-making.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
English
Journal:
The Singapore Family Physician
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS